Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | MTOR | P42345 | 1/20 | 0.41 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.41 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.41 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.41 |
| ▸ | P2RY14 | Q15391 | 5/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | P2RY2 | P41231 | 5/20 | 0.38 |
| ▸ | P2RY6 | Q15077 | 5/20 | 0.38 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.38 |
| ▸ | P2RY4 | P51582 | 4/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cytosine SCHEMBL9768402 | 0.92 | P2RY14 (0.45) | ALDH1A1P2RY14P2RY2P2RY6P2RY4 | |
| Cytosine SCHEMBL672261 | 0.90 | P2RY6 (0.46) | ALDH1A1P2RY14P2RY2P2RY6P2RY4 | |
| Ribose (Furanose) SCHEMBL3341287 | 0.82 | LMNA (0.49) | ALDH1A1LMNATHRBMTORMDM2 | |
| Ribose (Furanose) SCHEMBL8833 | 0.82 | LMNA (0.49) | ALDH1A1LMNATHRBMTORMDM2 | |
| Ribose (Furanose) SCHEMBL2325834 | 0.82 | LMNA (0.49) | ALDH1A1LMNATHRBMTORMDM2 | |
| Ribose (Furanose) SCHEMBL142622 | 0.82 | LMNA (0.49) | ALDH1A1LMNATHRBMTORMDM2 | |
| SCHEMBL5369246 | 0.81 | P2RY14 (0.39) | ALDH1A1P2RY14P2RY2P2RY6ADORA1 | |
| Ribose (Furanose) SCHEMBL628713 | 0.81 | LMNA (0.48) | ALDH1A1LMNATHRBMTORMDM2 | |
| Ribose (Furanose) SCHEMBL561196 | 0.81 | LMNA (0.48) | ALDH1A1LMNATHRBMTORMDM2 | |
| Cytosine SCHEMBL11321353 | 0.79 | FBP1 (0.47) | P2RY14P2RY2P2RY6P2RY4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230110614-A1 | HEPARIN AND N-ACETYLCYSTEINE FOR THE TREATMENT OF A RESPIRATORY VIRUS | ATOSSA THERAPEUTICS, INC. | 2023-04-13 | — | — | US | claimed |
| EP-4125936-A1 | HEPARIN AND N-ACETYLCYSTEINE FOR THE TREATMENT OF A RESPIRATORY VIRUS | Atossa Therapeutics, Inc. (US) | 2023-02-08 | — | — | EP | claimed |
| WO-2021194890-A1 | HEPARIN AND N-ACETYLCYSTEINE FOR THE TREATMENT OF A RESPIRATORY VIRUS | ATOSSA THERAPEUTICS, INC. (US) | 2021-09-30 | — | — | WO | claimed |
| US-4701521-A | BONDING TO CATIONIC POLYMER | THE TRUSTEES OF BOSTON UNIVERSITY (US) | 1987-10-20 | — | — | US | claimed |
| EP-0009498-B1 | EFFECTING CELLULAR UPTAKE OF MOLECULES | TRUSTEES OF BOSTON UNIVERSITY (US) | 1984-06-27 | — | — | EP | claimed |
| EP-0009498-A4 | EFFECTING CELLULAR UPTAKE OF MOLECULES. | UNIV BOSTON (US) | 1980-10-16 | — | — | EP | claimed |
| EP-0009498-A1 | EFFECTING CELLULAR UPTAKE OF MOLECULES. | UNIV BOSTON (US) | 1980-04-16 | — | — | EP | claimed |
| WO-1979000515-A1 | METHOD OF EFFECTING CELLULAR UPTAKE OF MOLECULES | UNIV BOSTON (US) | 1979-08-09 | — | — | WO | claimed |
| US-12576103-B2 | Heparin and N-acetylcysteine for the treatment of lung injury | ATOSSA THERAPEUTICS, INC. (US) | 2026-03-17 | — | — | US | disclosed |
| WO-2024189607-A1 | METHODS AND BIOAVAILABLE HIGHLY PERMEABLE COMPOUNDS FOR DISEASES TREATMENT | DIDENKO KIRILL (MX) | 2024-09-19 | — | — | WO | disclosed |
| US-20230278957-A1 | TREX1 INHIBITORS AND USES THEREOF | UNIV WAKE FOREST HEALTH SCIENCES (US) | 2023-09-07 | — | — | US | disclosed |
| US-20230110614-A1 | HEPARIN AND N-ACETYLCYSTEINE FOR THE TREATMENT OF A RESPIRATORY VIRUS | ATOSSA THERAPEUTICS, INC. | 2023-04-13 | — | — | US | disclosed |
| US-20230105879-A1 | Antiviral Composition | KLELE LUKE (US) | 2023-04-06 | — | — | US | disclosed |
| EP-4135660-A1 | COMPOSITIONS AND METHODS TO REDUCE THE INFECTIVITY OF A VIRUS | Atossa Therapeutics, Inc. (US) | 2023-02-22 | — | — | EP | disclosed |
| US-4847240-A | CATIONIC POLYMERS AS TRANSPORT CARRIERS | THE TRUSTEES OF BOSTON UNIVERSITY (US) | 1989-07-11 | — | — | US | disclosed |
| US-4701521-A | BONDING TO CATIONIC POLYMER | THE TRUSTEES OF BOSTON UNIVERSITY (US) | 1987-10-20 | — | — | US | disclosed |
| EP-0009498-B1 | EFFECTING CELLULAR UPTAKE OF MOLECULES | TRUSTEES OF BOSTON UNIVERSITY (US) | 1984-06-27 | — | — | EP | disclosed |
| EP-0009498-A4 | EFFECTING CELLULAR UPTAKE OF MOLECULES. | UNIV BOSTON (US) | 1980-10-16 | — | — | EP | disclosed |
| EP-0009498-A1 | EFFECTING CELLULAR UPTAKE OF MOLECULES. | UNIV BOSTON (US) | 1980-04-16 | — | — | EP | disclosed |
| WO-1979000515-A1 | METHOD OF EFFECTING CELLULAR UPTAKE OF MOLECULES | UNIV BOSTON (US) | 1979-08-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230278957-A1 | TREX1 INHIBITORS AND USES THEREOF | STING1, CGAS, MAVS | ALDH1A1 3221/4885LMNA 1096/4885THRB 1247/4885 |
| US-20230105879-A1 | Antiviral Composition | MAVS, SARS1, ACE2 | ALDH1A1 1990/4885LMNA 1965/4885THRB 2647/4885 |
| US-12576103-B2 | Heparin and N-acetylcysteine for the treatment of lung injury | SERPINC1, TXNRD2, TXN | ALDH1A1 3305/4885LMNA 2782/4885THRB 1561/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.